Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT01853709
Other study ID # CSPT-END-DIG-2012
Secondary ID
Status Not yet recruiting
Phase Phase 4
First received April 29, 2013
Last updated May 9, 2013
Start date May 2013
Est. completion date December 2013

Study information

Verified date May 2013
Source Corporacion Parc Tauli
Contact Félix Junquera, PhD
Phone 34937458320
Email fjunquera@tauli.cat
Is FDA regulated No
Health authority Spain: Agencia Española de Medicamentos y Productos Sanitarios
Study type Interventional

Clinical Trial Summary

Colonoscopy is the gold standard diagnostic procedure for colonic disease. Excellent bowel cleansing is critical for this procedure. However, an inadequate bowel cleansing is a common problem that occurs up to 20% of procedures. This fact has a deep clinical and economical impact. In fact, inadequate bowel preparation is associated to misdiagnosis in 30% of lesions. Moreover several clinical conditions such as cirrhosis, antidepressant drugs, and hospitalized patients are predictive factors of inadequate colonic preparations. These circumstances have promoted multiple clinical trials, however there is no consensus about the optimal strategy for colonic cleansing. Education in colonic preparation has obtained conflicting results. Polyethylene glycol (PEG) and sodium phosphate solutions have been the commonest preparations used with a similar efficacy. However, the large volume to ingest (4 litters) makes PEG compliance difficult. Likewise, sodium phosphate also contains high levels in sodium and phosphate which contraindicate its use in elderly patients and / or with comorbidity. The use of adjuvants such as olive oil and bisacodyl allows reducing the volume of polyethylene glycol thereby improving the tolerance and right colon preparation.

The aim of this study is to compare the efficacy of a multidisciplinary approach (education, fiber free diet, polyethylene glycol (PEG) 2L, and adjuvant bisacodyl + olive oil) vs. a conventional approach (fiber free diet+ PEG 4L in split doses ) in cleaning the colon of hospitalized patients.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 162
Est. completion date December 2013
Est. primary completion date December 2013
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Hospitalized patients who undergo a non urgent colonoscopy

- Patients who give informed consent to participate in the study

- Patients older than 18 years

- Patients who undergo total colonoscopy

Exclusion Criteria:

- Non compliance with the 48 hours diet prescribed

- The endoscopy planned is a rectosigmoidoscopy

- Previous colonic surgery

- Mental/cognitive impairment preventing the study assessments

- Severe renal failure

- Electrolytic disbalance(hyponatremia, hypokaliemia, Hyperphosphatemia, hypocalcemia and hypomagnesemia)

- Intestinal obstruction, perforation or toxic megacolon

- Pregnant or nursing women

- Allergy/intolerance to PEG, bisacodyl or adjuvants

- No informed consent

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Bowel Preparation for Colonoscopy

Intervention

Behavioral:
Education

Other:
Fiber free diet

Dietary Supplement:
Adjuvants

Drug:
Polyethylene glycol (PEG)

Bisacodyl


Locations

Country Name City State
Spain Hospital de Sabadell Sabadell Barcelona

Sponsors (1)

Lead Sponsor Collaborator
Corporacion Parc Tauli

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary percentage of patients with adequate bowel preparation Adequate bowel preparation is defined as a preparation which allows exploring the whole colonic mucose and detecting flat lesions (Rating as good or excellent in the Boston Bowel preparation scale) at the time of performing the colonoscopy No
Secondary Percentage of patients with adequate bowel preparation by bowel segments The boston scale will be assessed by the investigators during the procedure. At the time of performing the colonoscopy No
Secondary Tolerance to the colonoscopy Tolerance to the colonoscopy will be measured by VAS during the colonoscopy, 30 minutes after colonoscopy and 24 hours after colonoscopy from colonoscopy up to 24 hours after colonoscopy Yes
Secondary Percentage of complete/incomplete colonoscopies and reprogramming Evaluation of incomplete or inadequate bowel preparation will be assessed after performing the colonoscopy After the colonoscopy No
Secondary Complications during and after the procedure up to 24 hours after colonoscopy Yes
Secondary Doses of sedation needed during the colonoscopy Final dose will be calculated at the end of the procedure During the colonoscopy process No
Secondary Tolerance to the preparation up to 48 hours Yes
Secondary Endoscopic findings during the colonoscopy No
See also
  Status Clinical Trial Phase
Completed NCT02839824 - Evaluation of the Quality of Bowel Cleansing in a Real Clinical Practice Setting N/A
Completed NCT01719653 - A Comparison of 5 Low Volume Bowel Preparations Phase 4
Completed NCT01929590 - Low-volume Polyethylene Glycol Bowel Preparation for Colonoscopy Phase 3
Completed NCT00611442 - Split Dose Golytely With Amitiza Pretreatment Versus Split Dose Golytely Plus Placebo in Outpatient Colonoscopy N/A
Recruiting NCT01028573 - A Study Comparing PEG-3350 (Miralax) and Gatorade With PEG-ELS (Golytely) for Bowel Preparation Prior to Colonoscopy N/A
Completed NCT05291325 - Application of Linaclotide Capsule in Bowel Preparation for Colonoscopy N/A
Completed NCT01415687 - Split Dose Pico-Salax + Bisacodyl vs. PEG Split Dose Phase 3
Completed NCT05465889 - Efficacy and Safety of Oral Sulfate Solution on Bowel Preparation for Colonoscopy Phase 3
Completed NCT03055689 - Bowel Preparation for Repeat Colonoscopy After Preparation Failure (RepeatPrep Study) N/A
Completed NCT02376465 - A Pilot Evaluation of an Experimental BLI4600 Formulation for Bowel Preparation in Adult Patients Undergoing Colonoscopy Phase 2
Completed NCT01765491 - Comparison of Two Methods of Bowel Preparation for Colonoscopy in Hospitalized Patients N/A